Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction.

Gemma VilahurMonika RadikePablo SutelmanSoumaya Ben-AichaManuel GutiérrezLaura CasaníDaniel HovdalEmily L OngstadAnders GabrielsenAlberto HidalgoOla FjellströmLeif CarlssonLina Badimón

Published in: European heart journal (2024)

Infusion of AZD3366 on top of ticagrelor leads to enhanced cardioprotection compared with ticagrelor alone.

Keyphrases

acute coronary syndrome
percutaneous coronary intervention
recombinant human
st elevation myocardial infarction
st segment elevation myocardial infarction
antiplatelet therapy
coronary artery disease
heart failure
low dose
left ventricular
atrial fibrillation